Lykis Ltd
₹ 42.6
0.40%
22 Nov
- close price
- Market Cap ₹ 82.6 Cr.
- Current Price ₹ 42.6
- High / Low ₹ 82.6 / 39.5
- Stock P/E 103
- Book Value ₹ 16.8
- Dividend Yield 0.00 %
- ROCE 5.40 %
- ROE 2.20 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Stock is trading at 2.54 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 11.1% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.3.63 Cr.
- Promoter holding has decreased over last 3 years: -11.8%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 119 | 167 | 104 | 106 | 148 | 146 | 84 | 59 | 317 | 432 | 371 | 358 | |
16 | 118 | 164 | 101 | 105 | 146 | 143 | 85 | 70 | 320 | 413 | 366 | 353 | |
Operating Profit | -1 | 1 | 3 | 4 | 1 | 2 | 4 | -1 | -11 | -3 | 19 | 6 | 5 |
OPM % | -6% | 1% | 2% | 4% | 1% | 2% | 2% | -1% | -20% | -1% | 4% | 2% | 1% |
1 | 2 | 1 | 1 | 3 | 3 | -1 | 2 | 1 | 6 | 3 | 3 | 4 | |
Interest | 0 | 1 | 2 | 2 | 3 | 5 | 2 | 3 | 2 | 3 | 6 | 7 | 6 |
Depreciation | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 1 | 2 |
Profit before tax | -0 | 1 | 2 | 2 | 1 | -0 | -0 | -1 | -13 | -1 | 14 | 0 | 1 |
Tax % | 36% | 32% | 18% | 24% | 24% | 21% | 131% | -14% | -18% | -18% | 28% | -36% | |
-0 | 1 | 1 | 2 | 0 | -0 | -1 | -1 | -11 | -1 | 10 | 1 | 1 | |
EPS in Rs | -0.10 | 0.47 | 0.79 | 0.92 | 0.22 | -0.24 | -0.50 | -0.59 | -5.61 | -0.38 | 5.09 | 0.35 | 0.42 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 20% |
3 Years: | 85% |
TTM: | -9% |
Compounded Profit Growth | |
---|---|
10 Years: | -1% |
5 Years: | 8% |
3 Years: | 27% |
TTM: | -89% |
Stock Price CAGR | |
---|---|
10 Years: | 1% |
5 Years: | 20% |
3 Years: | 11% |
1 Year: | -29% |
Return on Equity | |
---|---|
10 Years: | 0% |
5 Years: | -2% |
3 Years: | 11% |
Last Year: | 2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 15 | 19 | 19 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
Reserves | 6 | 9 | 10 | 14 | 15 | 14 | 14 | 12 | 1 | 1 | 11 | 11 | 13 |
2 | 45 | 62 | 52 | 86 | 113 | 43 | 49 | 45 | 110 | 130 | 88 | 79 | |
10 | 6 | 10 | 24 | 10 | 43 | 36 | 11 | 26 | 10 | 10 | 17 | 15 | |
Total Liabilities | 33 | 79 | 100 | 110 | 131 | 191 | 112 | 92 | 93 | 141 | 171 | 136 | 126 |
12 | 12 | 11 | 13 | 13 | 14 | 13 | 15 | 3 | 4 | 5 | 5 | 4 | |
CWIP | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 10 | 5 | 12 | 3 | 5 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
21 | 56 | 82 | 84 | 115 | 171 | 97 | 75 | 88 | 135 | 164 | 130 | 120 | |
Total Assets | 33 | 79 | 100 | 110 | 131 | 191 | 112 | 92 | 93 | 141 | 171 | 136 | 126 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-11 | -29 | -23 | 16 | -34 | 1 | 36 | 9 | -16 | -74 | -9 | 52 | |
-0 | -11 | 4 | -8 | 9 | 0 | 2 | -2 | 9 | 10 | -0 | -1 | |
14 | 45 | 16 | -6 | 33 | 23 | -68 | -6 | 7 | 63 | 10 | -49 | |
Net Cash Flow | 3 | 5 | -2 | 2 | 9 | 25 | -30 | 1 | 0 | -2 | 1 | 3 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 162 | 60 | 96 | 105 | 154 | 113 | 87 | 113 | 149 | 76 | 95 | 91 |
Inventory Days | 52 | 4 | 4 | 12 | 8 | 17 | 12 | 4 | 80 | 18 | 15 | 11 |
Days Payable | 99 | 12 | 17 | 10 | 20 | 17 | 43 | 25 | 53 | 11 | 6 | 11 |
Cash Conversion Cycle | 115 | 52 | 83 | 106 | 143 | 114 | 56 | 92 | 176 | 82 | 105 | 90 |
Working Capital Days | 297 | 130 | 146 | 186 | 301 | 201 | 124 | 178 | 292 | 138 | 127 | 103 |
ROCE % | 1% | 5% | 4% | 5% | 3% | 3% | 3% | 2% | -15% | 1% | 14% | 5% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Nov
- Unaudited Financial Result For The Period Ended September 30, 2024 1 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting
1 Nov - Board approved un-audited financial results for Q2 2024.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 22 Oct
-
Board Meeting Intimation for Consideration And Approval Of Un - Audited Financial Result For The Quarter And Half Year Ended September 30, 2024
17 Oct - Board meeting to approve financial results on November 1, 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company offers manufacturing support for private labelling in domestic and 40+ countries